Investigators have identified an inverse association between adenoma detection rate (ADR) and postcolonoscopy colorectal cancer risk (PCCRC) following the utilization of a fecal immunochemical test (FIT).
A team, led by Manuel Zorzi, MD, MSc, Veneto Tumor Registry, Azienda Zero, examined the association between adenoma detection rate and postcolonoscpy colorectal cancer risk in a fecal immunochemical test-based screening program in northeastern Italy.
